Verition Fund Management LLC Tenaya Therapeutics, Inc. Transaction History
Verition Fund Management LLC
- $16.5 Billion
- Q2 2024
A detailed history of Verition Fund Management LLC transactions in Tenaya Therapeutics, Inc. stock. As of the latest transaction made, Verition Fund Management LLC holds 11,513 shares of TNYA stock, worth $23,601. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,513Holding current value
$23,601% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding TNYA
# of Institutions
99Shares Held
56.1MCall Options Held
30.3KPut Options Held
600-
Column Group LLC San Francisco, CA9.4MShares$19.3 Million40.92% of portfolio
-
Ra Capital Management, L.P. Boston, MA7.62MShares$15.6 Million0.36% of portfolio
-
Casdin Capital, LLC New York, NY6.73MShares$13.8 Million1.8% of portfolio
-
Black Rock Inc. New York, NY4.07MShares$8.35 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.51MShares$7.2 Million0.0% of portfolio
About Tenaya Therapeutics, Inc.
- Ticker TNYA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,364,700
- Market Cap $84.8M
- Description
- Tenaya Therapeutics, Inc., a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. It develops its products through cellular regeneration, gene therapy, and precision medicine platforms. The company is developing TN-201, an adeno-associated virus (AAV)-based gene therapy to address genetic hyp...